Absci ABSI
NASDAQ ABSI
$8.82 +0.02 (+0.23%)
As of: Sep 4, 2026 · 2:36 PM EDT

Absci (ABSI) Goodwill & Intangibles (2021 - 2026)

Absci (ABSI) posted Goodwill & Intangibles of $40.8 million for Q1 2026, down 1.8% sequentially from $41.5 million in Q4 2025, and down 7.43% YoY from $44.0 million in Q1 2025.

Analysis

Absci (ABSI) Goodwill & Intangibles (2021 - 2026) Analysis & Trends

Absci has reported Goodwill & Intangibles for 6 years, with the latest figure at $40.8 million in Q1 2026.

  • Quarterly Goodwill & Intangibles fell 7.43% year-over-year to $40.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.8 million (down 7.43% YoY) and the FY2025 annual result came in at $41.5 million, down 7.51% from the prior year.
  • Goodwill & Intangibles retreated to $40.8 million in Q1 2026 per ABSI's latest filing, from $41.5 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $74.6 million in Q2 2022 and troughed at $40.8 million in Q1 2026.
  • A 5-year average of $53.5 million and a median of $47.4 million in 2024 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2023 and 2024: Goodwill & Intangibles dropped 1.15% in 2023, then plunged 34.26% in 2024.
  • Over 5 years, Goodwill & Intangibles stood at $73.0 million in 2022, then tumbled by 33.86% to $48.3 million in 2023, then slipped by 6.98% to $44.9 million in 2024, then declined by 7.51% to $41.5 million in 2025, then retreated by 1.8% to $40.8 million in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $40.8 million, $41.5 million, and $42.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Absci 1.39 Bn 1.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.05 Mn
Mar 31, 2026 40.77 Mn
Dec 31, 2025 41.51 Mn
Sep 30, 2025 42.36 Mn
Jun 30, 2025 43.20 Mn
Mar 31, 2025 44.04 Mn
Dec 31, 2024 44.88 Mn
Sep 30, 2024 45.73 Mn
Jun 30, 2024 46.57 Mn
Mar 31, 2024 47.41 Mn
Dec 31, 2023 48.25 Mn
Sep 30, 2023 49.10 Mn
Jun 30, 2023 49.94 Mn
Mar 31, 2023 72.12 Mn
Dec 31, 2022 72.96 Mn
Sep 30, 2022 73.80 Mn
Jun 30, 2022 74.64 Mn
Mar 31, 2022 78.44 Mn
Dec 31, 2021 76.33 Mn
Sep 30, 2021 78.85 Mn